A. Tourkantonis
About
In The Last Decade
A. Tourkantonis
42 papers receiving 754 citations
Peers
Comparison fields: 5 of 99
- Nephrology 470
- Surgery 265
- Cardiology and Cardiovascular Medicine 108
- Physiology 96
- Psychiatry and Mental health 87
Countries citing papers authored by A. Tourkantonis
This map shows the geographic impact of A. Tourkantonis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Tourkantonis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Tourkantonis more than expected).
Fields of papers citing papers by A. Tourkantonis
This network shows the impact of papers produced by A. Tourkantonis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Tourkantonis. The network helps show where A. Tourkantonis may publish in the future.
Co-authorship network of co-authors of A. Tourkantonis
This figure shows the co-authorship network connecting the top 25 collaborators of A. Tourkantonis. A scholar is included among the top collaborators of A. Tourkantonis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Tourkantonis. A. Tourkantonis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 28 | |
| 2 | 5 | |
| 3 | Cardiorespiratory adaptations to long-term physical training in dialysis patients | 1 |
| 4 | Hypertension in chronic hemodialysis patients: current view on pathophysiology and treatment. | 25 |
| 5 | Effective treatment of secondary hyperparathyroidism in hemodialysis patients by titration of intravenous calcitriol dosage. | 7 |
| 6 | 253 | |
| 7 | 23 | |
| 8 | 123 | |
| 9 | 7 | |
| 10 | 34 | |
| 11 | Procollagen-I and collagen-I in the serum and dialysate of CAPD patients: changes over time. | 3 |
| 12 | 6 | |
| 13 | Post-operative intracarotid chemotherapy followed by radiation therapy in patients with malignant gliomas. A Phase II study. | 2 |
| 14 | 3 | |
| 15 | 13 | |
| 16 | 14 | |
| 17 | [Combined therapy of locally advanced squamous epithelial cancers in the area of the head and neck]. | 2 |
| 18 | Severe orthostatic hypotension due to Bartter's syndrome. | 2 |
| 19 | Biocompatibility of cuprophan and cellulose acetate membranes. Prevention of dialysis hypoxemia and leucopenia by ticlopidine. | 2 |
| 20 | CLINICAL AND LABORATORY EXPERIENCE WITH LINCOMYCIN. | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.